Covid-19 Impact on Global Recombinant Human Granulocyte Colony-Stimulating Market Insights, Forecast to 2026
Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.
Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Human Granulocyte Colony-Stimulating market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Human Granulocyte Colony-Stimulating industry.
Based on our recent survey, we have several different scenarios about the Recombinant Human Granulocyte Colony-Stimulating YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Human Granulocyte Colony-Stimulating will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Human Granulocyte Colony-Stimulating market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Human Granulocyte Colony-Stimulating market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Recombinant Human Granulocyte Colony-Stimulating market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Recombinant Human Granulocyte Colony-Stimulating market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant Human Granulocyte Colony-Stimulating market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Human Granulocyte Colony-Stimulating market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Human Granulocyte Colony-Stimulating market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Human Granulocyte Colony-Stimulating market.
The following manufacturers are covered in this report:
Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Human Granulocyte Colony-Stimulating market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Human Granulocyte Colony-Stimulating industry.
Based on our recent survey, we have several different scenarios about the Recombinant Human Granulocyte Colony-Stimulating YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Human Granulocyte Colony-Stimulating will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Human Granulocyte Colony-Stimulating market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Human Granulocyte Colony-Stimulating market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Recombinant Human Granulocyte Colony-Stimulating market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Recombinant Human Granulocyte Colony-Stimulating market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant Human Granulocyte Colony-Stimulating market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Human Granulocyte Colony-Stimulating market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Human Granulocyte Colony-Stimulating market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Human Granulocyte Colony-Stimulating market.
The following manufacturers are covered in this report:
- Amgen
- Qilu Pharmaceutical
- Shijiazhuang Pharmaceutical
- Kyowa Hakko Kirin
- Gensci
- Amoytop Biotech
- Hangzhou Jiuyuan
- Huaxin
- Triprime
- Sinovac
- Zhaoke
- Kawin
- Lenograstim (Granocyte)
- Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
- Others
- Chemotherapy Induced Neutropenia
- Before Blood Donation
- Stem Cell Transplants
- Others
1 STUDY COVERAGE
1.1 Recombinant Human Granulocyte Colony-Stimulating Product Introduction
1.2 Market Segments
1.3 Key Recombinant Human Granulocyte Colony-Stimulating Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type
1.4.2 Lenograstim (Granocyte)
1.4.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application
1.5.2 Chemotherapy Induced Neutropenia
1.5.3 Before Blood Donation
1.5.4 Stem Cell Transplants
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Human Granulocyte Colony-Stimulating Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Human Granulocyte Colony-Stimulating Industry
1.6.1.1 Recombinant Human Granulocyte Colony-Stimulating Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Human Granulocyte Colony-Stimulating Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Human Granulocyte Colony-Stimulating Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts
2.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2015-2026
2.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2015-2026
2.2 Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2020 Versus 2026
2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING COMPETITOR LANDSCAPE BY PLAYERS
3.1 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers
3.1.1 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers
3.2.1 Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Human Granulocyte Colony-Stimulating Revenue in 2019
3.2.5 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Human Granulocyte Colony-Stimulating Price by Manufacturers
3.4 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Granulocyte Colony-Stimulating Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Type (2015-2020)
4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2015-2020)
4.1.3 Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Application (2015-2020)
5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020)
5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2015-2020)
5.1.3 Recombinant Human Granulocyte Colony-Stimulating Price by Application (2015-2020)
5.2 Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Recombinant Human Granulocyte Colony-Stimulating by Country
6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
6.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
7 EUROPE
7.1 Europe Recombinant Human Granulocyte Colony-Stimulating by Country
7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country
7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating by Region
8.1.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region
8.1.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Recombinant Human Granulocyte Colony-Stimulating by Country
9.1.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
9.1.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
9.3 Central & South America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Country
10.1.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country
10.1.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.1.5 Amgen Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Corporation Information
11.2.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Shijiazhuang Pharmaceutical
11.3.1 Shijiazhuang Pharmaceutical Corporation Information
11.3.2 Shijiazhuang Pharmaceutical Description, Business Overview and Total Revenue
11.3.3 Shijiazhuang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.3.5 Shijiazhuang Pharmaceutical Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Corporation Information
11.4.2 Kyowa Hakko Kirin Description, Business Overview and Total Revenue
11.4.3 Kyowa Hakko Kirin Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Gensci
11.5.1 Gensci Corporation Information
11.5.2 Gensci Description, Business Overview and Total Revenue
11.5.3 Gensci Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.5.5 Gensci Recent Development
11.6 Amoytop Biotech
11.6.1 Amoytop Biotech Corporation Information
11.6.2 Amoytop Biotech Description, Business Overview and Total Revenue
11.6.3 Amoytop Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.6.5 Amoytop Biotech Recent Development
11.7 Hangzhou Jiuyuan
11.7.1 Hangzhou Jiuyuan Corporation Information
11.7.2 Hangzhou Jiuyuan Description, Business Overview and Total Revenue
11.7.3 Hangzhou Jiuyuan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.7.5 Hangzhou Jiuyuan Recent Development
11.8 Huaxin
11.8.1 Huaxin Corporation Information
11.8.2 Huaxin Description, Business Overview and Total Revenue
11.8.3 Huaxin Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.8.5 Huaxin Recent Development
11.9 Triprime
11.9.1 Triprime Corporation Information
11.9.2 Triprime Description, Business Overview and Total Revenue
11.9.3 Triprime Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.9.5 Triprime Recent Development
11.10 Sinovac
11.10.1 Sinovac Corporation Information
11.10.2 Sinovac Description, Business Overview and Total Revenue
11.10.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.10.5 Sinovac Recent Development
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.1.5 Amgen Recent Development
11.12 Kawin
11.12.1 Kawin Corporation Information
11.12.2 Kawin Description, Business Overview and Total Revenue
11.12.3 Kawin Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kawin Products Offered
11.12.5 Kawin Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Region
12.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Human Granulocyte Colony-Stimulating Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Recombinant Human Granulocyte Colony-Stimulating Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Recombinant Human Granulocyte Colony-Stimulating Product Introduction
1.2 Market Segments
1.3 Key Recombinant Human Granulocyte Colony-Stimulating Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type
1.4.2 Lenograstim (Granocyte)
1.4.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application
1.5.2 Chemotherapy Induced Neutropenia
1.5.3 Before Blood Donation
1.5.4 Stem Cell Transplants
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Human Granulocyte Colony-Stimulating Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Human Granulocyte Colony-Stimulating Industry
1.6.1.1 Recombinant Human Granulocyte Colony-Stimulating Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Human Granulocyte Colony-Stimulating Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Human Granulocyte Colony-Stimulating Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts
2.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2015-2026
2.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2015-2026
2.2 Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2020 Versus 2026
2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING COMPETITOR LANDSCAPE BY PLAYERS
3.1 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers
3.1.1 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers
3.2.1 Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Human Granulocyte Colony-Stimulating Revenue in 2019
3.2.5 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Human Granulocyte Colony-Stimulating Price by Manufacturers
3.4 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Granulocyte Colony-Stimulating Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Type (2015-2020)
4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2015-2020)
4.1.3 Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Application (2015-2020)
5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020)
5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2015-2020)
5.1.3 Recombinant Human Granulocyte Colony-Stimulating Price by Application (2015-2020)
5.2 Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Recombinant Human Granulocyte Colony-Stimulating by Country
6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
6.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
7 EUROPE
7.1 Europe Recombinant Human Granulocyte Colony-Stimulating by Country
7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country
7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating by Region
8.1.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region
8.1.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Recombinant Human Granulocyte Colony-Stimulating by Country
9.1.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
9.1.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
9.3 Central & South America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Country
10.1.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country
10.1.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.1.5 Amgen Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Corporation Information
11.2.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Shijiazhuang Pharmaceutical
11.3.1 Shijiazhuang Pharmaceutical Corporation Information
11.3.2 Shijiazhuang Pharmaceutical Description, Business Overview and Total Revenue
11.3.3 Shijiazhuang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.3.5 Shijiazhuang Pharmaceutical Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Corporation Information
11.4.2 Kyowa Hakko Kirin Description, Business Overview and Total Revenue
11.4.3 Kyowa Hakko Kirin Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Gensci
11.5.1 Gensci Corporation Information
11.5.2 Gensci Description, Business Overview and Total Revenue
11.5.3 Gensci Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.5.5 Gensci Recent Development
11.6 Amoytop Biotech
11.6.1 Amoytop Biotech Corporation Information
11.6.2 Amoytop Biotech Description, Business Overview and Total Revenue
11.6.3 Amoytop Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.6.5 Amoytop Biotech Recent Development
11.7 Hangzhou Jiuyuan
11.7.1 Hangzhou Jiuyuan Corporation Information
11.7.2 Hangzhou Jiuyuan Description, Business Overview and Total Revenue
11.7.3 Hangzhou Jiuyuan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.7.5 Hangzhou Jiuyuan Recent Development
11.8 Huaxin
11.8.1 Huaxin Corporation Information
11.8.2 Huaxin Description, Business Overview and Total Revenue
11.8.3 Huaxin Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.8.5 Huaxin Recent Development
11.9 Triprime
11.9.1 Triprime Corporation Information
11.9.2 Triprime Description, Business Overview and Total Revenue
11.9.3 Triprime Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.9.5 Triprime Recent Development
11.10 Sinovac
11.10.1 Sinovac Corporation Information
11.10.2 Sinovac Description, Business Overview and Total Revenue
11.10.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.10.5 Sinovac Recent Development
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
11.1.5 Amgen Recent Development
11.12 Kawin
11.12.1 Kawin Corporation Information
11.12.2 Kawin Description, Business Overview and Total Revenue
11.12.3 Kawin Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kawin Products Offered
11.12.5 Kawin Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Region
12.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Human Granulocyte Colony-Stimulating Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Recombinant Human Granulocyte Colony-Stimulating Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Recombinant Human Granulocyte Colony-Stimulating Market Segments
Table 2. Ranking of Global Top Recombinant Human Granulocyte Colony-Stimulating Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type 2020-2026 (KG) & (US$ Million)
Table 4. Major Manufacturers of Lenograstim (Granocyte)
Table 5. Major Manufacturers of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Recombinant Human Granulocyte Colony-Stimulating Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Recombinant Human Granulocyte Colony-Stimulating Players to Combat Covid-19 Impact
Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application 2020-2026 (KG)
Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (KG) & (US$ Million): 2020 VS 2026
Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Regions 2015-2020 (KG)
Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Regions (2015-2020)
Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers (2015-2020) (KG)
Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers (2015-2020)
Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2019)
Table 21. Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Price (2015-2020) (USD/g)
Table 24. Recombinant Human Granulocyte Colony-Stimulating Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
Table 26. Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2015-2020)
Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2015-2020)
Table 32. Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Type 2015-2020 (USD/g)
Table 33. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 34. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Application (2015-2020)
Table 35. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 36. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 37. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 39. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 40. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 41. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 42. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 43. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 44. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 45. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 47. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 48. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 50. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2015-2020) (KG)
Table 52. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 56. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 58. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 59. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 60. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 63. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 64. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 65. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 66. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 68. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 72. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 74. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Major Businesses
Table 77. Amgen Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 78. Amgen Product
Table 79. Amgen Recent Development
Table 80. Qilu Pharmaceutical Corporation Information
Table 81. Qilu Pharmaceutical Description and Major Businesses
Table 82. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Qilu Pharmaceutical Product
Table 84. Qilu Pharmaceutical Recent Development
Table 85. Shijiazhuang Pharmaceutical Corporation Information
Table 86. Shijiazhuang Pharmaceutical Description and Major Businesses
Table 87. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 88. Shijiazhuang Pharmaceutical Product
Table 89. Shijiazhuang Pharmaceutical Recent Development
Table 90. Kyowa Hakko Kirin Corporation Information
Table 91. Kyowa Hakko Kirin Description and Major Businesses
Table 92. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 93. Kyowa Hakko Kirin Product
Table 94. Kyowa Hakko Kirin Recent Development
Table 95. Gensci Corporation Information
Table 96. Gensci Description and Major Businesses
Table 97. Gensci Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 98. Gensci Product
Table 99. Gensci Recent Development
Table 100. Amoytop Biotech Corporation Information
Table 101. Amoytop Biotech Description and Major Businesses
Table 102. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 103. Amoytop Biotech Product
Table 104. Amoytop Biotech Recent Development
Table 105. Hangzhou Jiuyuan Corporation Information
Table 106. Hangzhou Jiuyuan Description and Major Businesses
Table 107. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 108. Hangzhou Jiuyuan Product
Table 109. Hangzhou Jiuyuan Recent Development
Table 110. Huaxin Corporation Information
Table 111. Huaxin Description and Major Businesses
Table 112. Huaxin Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 113. Huaxin Product
Table 114. Huaxin Recent Development
Table 115. Triprime Corporation Information
Table 116. Triprime Description and Major Businesses
Table 117. Triprime Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 118. Triprime Product
Table 119. Triprime Recent Development
Table 120. Sinovac Corporation Information
Table 121. Sinovac Description and Major Businesses
Table 122. Sinovac Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 123. Sinovac Product
Table 124. Sinovac Recent Development
Table 125. Zhaoke Corporation Information
Table 126. Zhaoke Description and Major Businesses
Table 127. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 128. Zhaoke Product
Table 129. Zhaoke Recent Development
Table 130. Kawin Corporation Information
Table 131. Kawin Description and Major Businesses
Table 132. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 133. Kawin Product
Table 134. Kawin Recent Development
Table 135. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions (2021-2026) (KG)
Table 136. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 140. North America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 142. Europe: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2021-2026) (KG)
Table 144. Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 146. Latin America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 148. Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Recombinant Human Granulocyte Colony-Stimulating Players
Table 153. Recombinant Human Granulocyte Colony-Stimulating Customers List
Table 154. Recombinant Human Granulocyte Colony-Stimulating Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 1. Recombinant Human Granulocyte Colony-Stimulating Market Segments
Table 2. Ranking of Global Top Recombinant Human Granulocyte Colony-Stimulating Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type 2020-2026 (KG) & (US$ Million)
Table 4. Major Manufacturers of Lenograstim (Granocyte)
Table 5. Major Manufacturers of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Recombinant Human Granulocyte Colony-Stimulating Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Recombinant Human Granulocyte Colony-Stimulating Players to Combat Covid-19 Impact
Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application 2020-2026 (KG)
Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (KG) & (US$ Million): 2020 VS 2026
Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Regions 2015-2020 (KG)
Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Regions (2015-2020)
Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers (2015-2020) (KG)
Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers (2015-2020)
Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2019)
Table 21. Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Price (2015-2020) (USD/g)
Table 24. Recombinant Human Granulocyte Colony-Stimulating Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
Table 26. Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2015-2020)
Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2015-2020)
Table 32. Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Type 2015-2020 (USD/g)
Table 33. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 34. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Application (2015-2020)
Table 35. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 36. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 37. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 39. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 40. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 41. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 42. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 43. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 44. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 45. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 47. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 48. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 50. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2015-2020) (KG)
Table 52. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 56. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 58. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 59. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 60. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 63. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 64. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 65. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 66. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 68. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2015-2020) (KG)
Table 72. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2015-2020) (KG)
Table 74. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Major Businesses
Table 77. Amgen Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 78. Amgen Product
Table 79. Amgen Recent Development
Table 80. Qilu Pharmaceutical Corporation Information
Table 81. Qilu Pharmaceutical Description and Major Businesses
Table 82. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Qilu Pharmaceutical Product
Table 84. Qilu Pharmaceutical Recent Development
Table 85. Shijiazhuang Pharmaceutical Corporation Information
Table 86. Shijiazhuang Pharmaceutical Description and Major Businesses
Table 87. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 88. Shijiazhuang Pharmaceutical Product
Table 89. Shijiazhuang Pharmaceutical Recent Development
Table 90. Kyowa Hakko Kirin Corporation Information
Table 91. Kyowa Hakko Kirin Description and Major Businesses
Table 92. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 93. Kyowa Hakko Kirin Product
Table 94. Kyowa Hakko Kirin Recent Development
Table 95. Gensci Corporation Information
Table 96. Gensci Description and Major Businesses
Table 97. Gensci Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 98. Gensci Product
Table 99. Gensci Recent Development
Table 100. Amoytop Biotech Corporation Information
Table 101. Amoytop Biotech Description and Major Businesses
Table 102. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 103. Amoytop Biotech Product
Table 104. Amoytop Biotech Recent Development
Table 105. Hangzhou Jiuyuan Corporation Information
Table 106. Hangzhou Jiuyuan Description and Major Businesses
Table 107. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 108. Hangzhou Jiuyuan Product
Table 109. Hangzhou Jiuyuan Recent Development
Table 110. Huaxin Corporation Information
Table 111. Huaxin Description and Major Businesses
Table 112. Huaxin Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 113. Huaxin Product
Table 114. Huaxin Recent Development
Table 115. Triprime Corporation Information
Table 116. Triprime Description and Major Businesses
Table 117. Triprime Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 118. Triprime Product
Table 119. Triprime Recent Development
Table 120. Sinovac Corporation Information
Table 121. Sinovac Description and Major Businesses
Table 122. Sinovac Recombinant Human Granulocyte Colony-Stimulating Production (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 123. Sinovac Product
Table 124. Sinovac Recent Development
Table 125. Zhaoke Corporation Information
Table 126. Zhaoke Description and Major Businesses
Table 127. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 128. Zhaoke Product
Table 129. Zhaoke Recent Development
Table 130. Kawin Corporation Information
Table 131. Kawin Description and Major Businesses
Table 132. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2015-2020)
Table 133. Kawin Product
Table 134. Kawin Recent Development
Table 135. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions (2021-2026) (KG)
Table 136. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 140. North America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 142. Europe: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2021-2026) (KG)
Table 144. Asia Pacific: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 146. Latin America: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2021-2026) (KG)
Table 148. Middle East and Africa: Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Recombinant Human Granulocyte Colony-Stimulating Players
Table 153. Recombinant Human Granulocyte Colony-Stimulating Customers List
Table 154. Recombinant Human Granulocyte Colony-Stimulating Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Recombinant Human Granulocyte Colony-Stimulating Product Picture
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020 & 2026
Figure 3. Lenograstim (Granocyte) Product Picture
Figure 4. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020 & 2026
Figure 7. Chemotherapy Induced Neutropenia
Figure 8. Before Blood Donation
Figure 9. Stem Cell Transplants
Figure 10. Others
Figure 11. Recombinant Human Granulocyte Colony-Stimulating Report Years Considered
Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size 2015-2026 (US$ Million)
Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Sales 2015-2026 (KG)
Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2019
Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Figure 18. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2019
Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Human Granulocyte Colony-Stimulating Revenue in 2019
Figure 21. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Figure 23. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2019
Figure 24. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2015-2020)
Figure 25. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type in 2019
Figure 26. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Price Range (2015-2020)
Figure 27. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Figure 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2019
Figure 29. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2015-2020)
Figure 30. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application in 2019
Figure 31. North America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 32. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 34. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 35. U.S. Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 36. U.S. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 38. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 40. North America Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 41. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 42. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 44. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 45. Germany Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 46. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 48. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 50. U.K. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 52. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 54. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 56. Europe Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 57. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 58. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2019
Figure 60. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2019
Figure 61. China Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 62. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 64. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 66. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 68. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 70. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 72. Taiwan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 74. Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 76. Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 78. Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 80. Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 82. Vietnam Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 84. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 85. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 86. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 88. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 89. Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 90. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 92. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 94. Argentina Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 96. Latin America Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 97. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 98. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 101. Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 102. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 104. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 106. U.A.E Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 108. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 109. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shijiazhuang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Gensci Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Amoytop Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Hangzhou Jiuyuan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Huaxin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Triprime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Zhaoke Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Kawin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 122. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 124. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 126. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 128. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 130. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. Recombinant Human Granulocyte Colony-Stimulating Product Picture
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020 & 2026
Figure 3. Lenograstim (Granocyte) Product Picture
Figure 4. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020 & 2026
Figure 7. Chemotherapy Induced Neutropenia
Figure 8. Before Blood Donation
Figure 9. Stem Cell Transplants
Figure 10. Others
Figure 11. Recombinant Human Granulocyte Colony-Stimulating Report Years Considered
Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size 2015-2026 (US$ Million)
Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Sales 2015-2026 (KG)
Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2019
Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Figure 18. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2019
Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Human Granulocyte Colony-Stimulating Revenue in 2019
Figure 21. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
Figure 23. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2019
Figure 24. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2015-2020)
Figure 25. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type in 2019
Figure 26. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Price Range (2015-2020)
Figure 27. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Figure 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2019
Figure 29. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2015-2020)
Figure 30. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application in 2019
Figure 31. North America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 32. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 34. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 35. U.S. Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 36. U.S. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 38. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 40. North America Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 41. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 42. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 44. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 45. Germany Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 46. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 48. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 50. U.K. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 52. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 54. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 56. Europe Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 57. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 58. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2019
Figure 60. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2019
Figure 61. China Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 62. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 64. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 66. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 68. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 70. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 72. Taiwan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 74. Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 76. Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 78. Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 80. Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 82. Vietnam Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 84. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 85. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 86. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 88. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 89. Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 90. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 92. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 94. Argentina Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 96. Latin America Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 97. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2015-2020 (KG)
Figure 98. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 101. Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 102. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 104. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 106. U.A.E Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2019
Figure 108. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2019
Figure 109. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shijiazhuang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Gensci Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Amoytop Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Hangzhou Jiuyuan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Huaxin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Triprime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Zhaoke Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Kawin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 122. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 124. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 126. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 128. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Forecast (2021-2026) (KG)
Figure 130. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
